Publication | Open Access

PEGylated tumor cell membrane vesicles as a new vaccine platform for cancer immunotherapy

VaccinationTumor ImmunologyImmunologyTherapeutic VaccineNew Vaccine PlatformCancer VaccinesTumor TargetingVaccine DesignImmunotherapyMedicineRadiation Oncology